Patent · US Active

Differentiation of human embryonic stem cells

US8785185B2 · kind B2 · utility

29Cited by
74References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 20, 2010
Grant dateJul 22, 2014
Priority date
Expiry dateAug 9, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/90
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides methods to promote the differentiation of pluripotent stem cells into cells expressing markers characteristic of the pancreatic endocrine lineage that co-express PDX1, NKX6.1, but do not express CDX2 and NGN3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.